CHRS

COHERUS ONCOLOGY INC

Healthcare | Micro Cap

-$0.29

EPS Forecast

$14.2

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.29

Revenue Forecast:

$14.2

EPS Surprise Forecast:

$0.004

Revenue Surprise Forecast:

-$0

Post-release price volatility - Very high

Post-release Overnight Move:

±11.9%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

57%

Probability of beating revenue consensus:

46%

Probability of beating both EPS & revs consensus:

32%

Probability of missing both EPS & revs consensus:

29%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

1.57

Earnings volatility

EPS standard deviation:

$0.05

Revenue standard deviation:

$3

As % of share price:

3.28% VERY HIGH

As % of market cap:

1.25% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.22

Revenue 95th %ile:

$18

EPS 75th %ile:

-$0.27

Revenue 75th %ile:

$15

EPS 25th %ile:

-$0.30

Revenue 25th %ile:

$13

EPS 5th %ile:

-$0.35

Revenue 5th %ile:

$11

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$100

Bid-ask per Share:

$0.015